141 related articles for article (PubMed ID: 6968922)
1. [Evaluation of cellular immunity in melanoma by means of a modified leukocyte migration inhibition test].
Bowszyc J; Bowszyc J; Wojnerowicz-Grajewska M; Milanowski L
Przegl Dermatol; 1980; 67(3):319-23. PubMed ID: 6968922
[No Abstract] [Full Text] [Related]
2. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
3. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
4. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
[No Abstract] [Full Text] [Related]
5. Immunologic mechanisms in malignant melanoma of the skin.
Cochran AJ
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
[No Abstract] [Full Text] [Related]
6. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic response in patients with melanoma of the skin].
Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunity to breast carcinoma and malignant melanoma.
Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity against malignant melanoma in monozygous twins.
Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
[No Abstract] [Full Text] [Related]
10. [Cutaneous, cellular immunity in malignant melanoma].
Kehrer HC
Wien Klin Wochenschr; 1991; 103(13):396-7. PubMed ID: 1897233
[No Abstract] [Full Text] [Related]
11. Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
Zheng M; Sun G; Cai S; Mueller R; Mrowietz U
Chin Med J (Engl); 1999 Jun; 112(6):493-6. PubMed ID: 11601324
[TBL] [Abstract][Full Text] [Related]
12. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676
[TBL] [Abstract][Full Text] [Related]
13. [Study of cellular immunity in post-traumatic iridocyclitis by means of the leukocyte migration inhibition test].
Arkhipova LT; Zaitseva NS; Iluridze SL; Gundorova RA
Oftalmol Zh; 1978; 33(8):565-6. PubMed ID: 570262
[No Abstract] [Full Text] [Related]
14. Cellular reaction to concanavalin A studied by the skin window method in healthy subjects and in patients with malignant tumors.
Kolár Z; Jansa P; Kovarík J; Skovránková H; Krcová I
Acta Univ Palacki Olomuc Fac Med; 1987; 117():73-80. PubMed ID: 2977713
[No Abstract] [Full Text] [Related]
15. [Modification of a micromethod for determining leukocyte migration inhibition and its significance in oncological patients].
Kochetkova VA
Lab Delo; 1980; (12):744-6. PubMed ID: 6163894
[No Abstract] [Full Text] [Related]
16. [Immunological conditions in patients with malignant melanoma of the skin].
Kristensen E
Ugeskr Laeger; 1976 Feb; 138(8):463-8. PubMed ID: 1258214
[No Abstract] [Full Text] [Related]
17. [Standardized recall antigen testing in patients with malignant melanoma, endogenous eczema patients and healthy humans].
Stenger D; Delbrück H; Krumrey K; Zaun H
Z Hautkr; 1983 Mar; 58(5):293-304. PubMed ID: 6845797
[TBL] [Abstract][Full Text] [Related]
18. [Determination of cellular hypersensitivity of delayed type in patients with rheumatism by the method of leukocyte migration inhibition].
Borisova AM
Vopr Revm; 1974; (4):3-9. PubMed ID: 4548604
[No Abstract] [Full Text] [Related]
19. [Immunological status of patients with solid neoplasms].
Citterio F; Luciani G; Pozzetto U; Castagneto M
Minerva Chir; 1980 May; 35(10):717-22. PubMed ID: 6969868
[No Abstract] [Full Text] [Related]
20. [T-cell immunity in syphilis patients].
Manuĭlova LA; Fedotov VP; Logunov VP
Vestn Dermatol Venerol; 1983 Mar; (3):23-7. PubMed ID: 6602434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
